Sales and Marketing

Showing 15 posts of 11520 posts found.

Pfizer buys anti-infective specialists Vicuron

June 17, 2005 Sales and Marketing

Pfizer has paid almost $2 billion for a US biopharmaceutical company with two promising anti-infective drugs.The acquisition of Vicuron Pharmaceuticals …

AZ fined E60 million by European Commission

June 16, 2005 Sales and Marketing

AstraZeneca has been fined E60 million by the European Commission for illegally trying to extend the patent on its ulcer …

Older painkillers linked to heart attack risk

June 14, 2005 Sales and Marketing

Two widely used painkillers ibuprofen and naproxen have been linked to increased rates of heart attacks in patients, a new …

BMS pays out $89 million in court settlement

June 14, 2005 Sales and Marketing

Bristol-Myers Squibb has reached a deal to pay $89 million to settle four lawsuits related to inflated inventories and other …

Hepatitis B market to double by 2010

June 14, 2005 Sales and Marketing

The hepatitis B market will double in size by 2010 and hit sales of $1 billion, according to analysts Datamonitor. …

Does practice make perfect targeting?

June 3, 2005 Sales and Marketing

Since the advent of brick sales information, numerous analytical techniques have become available to help identify the most valuable customers …

ABPI welcomes new report on animal research

June 1, 2005 Sales and Marketing

The ABPI has welcomed a new report on the ethics of animal research, agreeing the industry must challenge the need …

Pfizer becomes competitive in oncology

May 24, 2005 Research and Development, Sales and Marketing

Pfizer looks set to become a serious contender in oncology with its promising phase III kidney cancer drug Sutent.Until now …

Pharma and biotech target growing cancer sector

May 24, 2005 Sales and Marketing

Pharma and biotech companies presented a welter of data at this year's ASCO cancer conference, highlighting the growing importance of …

Shire plans four key drug filings

May 17, 2005 Sales and Marketing

Shire Pharmaceuticals hopes to strengthen its ADHD portfolio and establish itself in the global gastrointestinal market with a number of …

Roche raise sales expectations

May 12, 2005 Sales and Marketing

Roche has raised its full-year sales forecast after strong first quarter results saw the Swiss company outperform a number of …

Monoclonal antibody sales set to rocket

May 12, 2005 Sales and Marketing

The monoclonal antibody market will treble in size to $30 billion by 2010, according to a report by analysts Datamonitor.Datamonitor …

Novartis files novel iron overload treatment

May 12, 2005 Sales and Marketing

A new treatment for the rare and difficult to treat condition of chronic iron overload has been filed by Novartis …

FDA approves Requip for restless legs syndrome

May 12, 2005 Sales and Marketing

GlaxoSmithKline's Requip has become the first medicine to receive US approval for the treatment of restless legs syndrome (RLS), after …
The Gateway to Local Adoption Series

Latest content